Skip to main content
. 2018 Jun 8;9(44):27547–27563. doi: 10.18632/oncotarget.25547

Figure 1. Vorinostat increases the sensitivity of glioblastoma to ABT-888: Colony survival assay and derivation of CI values was conducted as described in methods.

Figure 1

Values are mean of surviving fraction ± S.E.M of triplicates. Stars represent significant differences between the surviving fraction of the combination treatment and each one of its components. **p<0.005.